Traditional Chinese medicine preparation for treating diabetic complications

Abstract

The invention belongs to the technical field of medicines for treating diabetes, and provides a traditional Chinese medicine preparation for treating diabetes complications in order to solve the problems of many complications existing in the process of oral Chinese medicine, western medicine and insulin injection for diabetic patients. It is prepared from mulberry leaves, ginkgo leaves, seabuckthorn leaves, schisandra chinensis, yam, chrysanthemum, bitter melon, buckwheat head, mulberry branches, astragalus, poria cocos, salvia miltiorrhiza, kudzu root, cassia seed, mulberry, Alisma, notoginseng, and coptis. become. The present invention can slowly lower blood sugar, can effectively prevent and delay the occurrence and development of diabetic complications, and has obvious therapeutic effects on complications caused by diabetes while assisting in lowering blood sugar and improving glucose tolerance; it can soften blood vessels, promote blood microcirculation, Regulate gastrointestinal function, improve mental status, improve sleep quality; effectively reduce the risk of developing complications of diabetes, reduce the economic burden of patients, improve the physical condition of patients, and improve the quality of life of patients.

Description

technical field [0001] The invention belongs to the technical field of medicines for treating diabetes, and in particular relates to a traditional Chinese medicine preparation for treating diabetic complications. Background technique [0002] Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia due to defects in insulin secretion or insulin action. Sustained high blood sugar and long-term metabolic disorders can lead to damage, dysfunction and failure of tissues and organs throughout the body, especially the eyes, kidneys, cardiovascular and nervous systems. Severe cases can cause acute complications such as dehydration, electrolyte disturbance and acid-base imbalance, ketoacidosis and hyperosmolar coma. [0003] In the past 30 years, the prevalence of diabetes in my country has increased significantly. In 1980, the epidemiological data of 300,000 people in 14 provinces and cities nationwide showed that the prevalence of diabetes was 0.7%. Fro...

AI Technical Summary

Problems solved by technology

[0008] At present, most of the drugs used to treat diabetes are directly used to lower blood sugar. For example, sulfonylurea hypoglycemic drugs (gliben, Damekang, etc.) lower blood sugar by promoting insulin secretion, and biguanide hypoglycemic drugs (metformin) improve insulin secretion by improving insulin secretion. Lowering blood sugar by inhibiting the absorption of sugar in the small intestine to lower postprandial blood sugar like Tangping does not fundamentally restore the body's self-regulatory system to health

Oral hypoglycemic drugs currently on the market cannot curb the functional decline of insulin secretion. Diabetic patients have defective insulin secretion function, and it will gradually worsen or even fail. This is why diabetes is a progressive disease.

Although the existing oral hypoglycemic drugs can effectively control blood sugar, they cannot effectively protect the patient's insulin secretion function for a long time, so the patient's function is still gradually declining with the passage of time, and the blood sugar of diabetic patients cannot be controlled. long-lasting effective control

Finally, patients can only rely on daily supplementation of exogenous insulin to control blood sugar, but can not treat complications caused by diabetes

Images